Copyright Reports & Markets. All rights reserved.

Global Orphan Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Orphan Drugs by Type
    • 1.3.1 Overview: Global Orphan Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Orphan Drugs Consumption Value Market Share by Type in 2023
    • 1.3.3 Oncology
    • 1.3.4 Pulmonary
    • 1.3.5 Neurology
    • 1.3.6 Hematology
    • 1.3.7 Endocrinology
    • 1.3.8 Cardio-vascular
    • 1.3.9 Metabolic Disorders
    • 1.3.10 Others
  • 1.4 Global Orphan Drugs Market by Application
    • 1.4.1 Overview: Global Orphan Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Baby and Child
    • 1.4.3 Teenager
    • 1.4.4 Adult
    • 1.4.5 Other
  • 1.5 Global Orphan Drugs Market Size & Forecast
  • 1.6 Global Orphan Drugs Market Size and Forecast by Region
    • 1.6.1 Global Orphan Drugs Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Orphan Drugs Market Size by Region, (2019-2030)
    • 1.6.3 North America Orphan Drugs Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Orphan Drugs Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Orphan Drugs Market Size and Prospect (2019-2030)
    • 1.6.6 South America Orphan Drugs Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Orphan Drugs Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bristol-Myers Squibb
    • 2.1.1 Bristol-Myers Squibb Details
    • 2.1.2 Bristol-Myers Squibb Major Business
    • 2.1.3 Bristol-Myers Squibb Orphan Drugs Product and Solutions
    • 2.1.4 Bristol-Myers Squibb Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bristol-Myers Squibb Recent Developments and Future Plans
  • 2.2 Roche
    • 2.2.1 Roche Details
    • 2.2.2 Roche Major Business
    • 2.2.3 Roche Orphan Drugs Product and Solutions
    • 2.2.4 Roche Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Roche Recent Developments and Future Plans
  • 2.3 Novartis
    • 2.3.1 Novartis Details
    • 2.3.2 Novartis Major Business
    • 2.3.3 Novartis Orphan Drugs Product and Solutions
    • 2.3.4 Novartis Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Novartis Recent Developments and Future Plans
  • 2.4 Johnson & Johnson
    • 2.4.1 Johnson & Johnson Details
    • 2.4.2 Johnson & Johnson Major Business
    • 2.4.3 Johnson & Johnson Orphan Drugs Product and Solutions
    • 2.4.4 Johnson & Johnson Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Johnson & Johnson Recent Developments and Future Plans
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Orphan Drugs Product and Solutions
    • 2.5.4 Pfizer Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Pfizer Recent Developments and Future Plans
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Orphan Drugs Product and Solutions
    • 2.6.4 Amgen Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Amgen Recent Developments and Future Plans
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Orphan Drugs Product and Solutions
    • 2.7.4 Sanofi Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Sanofi Recent Developments and Future Plans
  • 2.8 AstraZeneca
    • 2.8.1 AstraZeneca Details
    • 2.8.2 AstraZeneca Major Business
    • 2.8.3 AstraZeneca Orphan Drugs Product and Solutions
    • 2.8.4 AstraZeneca Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 AstraZeneca Recent Developments and Future Plans
  • 2.9 Takeda
    • 2.9.1 Takeda Details
    • 2.9.2 Takeda Major Business
    • 2.9.3 Takeda Orphan Drugs Product and Solutions
    • 2.9.4 Takeda Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Takeda Recent Developments and Future Plans
  • 2.10 Vertex Pharmaceuticals
    • 2.10.1 Vertex Pharmaceuticals Details
    • 2.10.2 Vertex Pharmaceuticals Major Business
    • 2.10.3 Vertex Pharmaceuticals Orphan Drugs Product and Solutions
    • 2.10.4 Vertex Pharmaceuticals Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Vertex Pharmaceuticals Recent Developments and Future Plans
  • 2.11 AbbVie
    • 2.11.1 AbbVie Details
    • 2.11.2 AbbVie Major Business
    • 2.11.3 AbbVie Orphan Drugs Product and Solutions
    • 2.11.4 AbbVie Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 AbbVie Recent Developments and Future Plans
  • 2.12 Biogen
    • 2.12.1 Biogen Details
    • 2.12.2 Biogen Major Business
    • 2.12.3 Biogen Orphan Drugs Product and Solutions
    • 2.12.4 Biogen Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Biogen Recent Developments and Future Plans
  • 2.13 Eli Lilly
    • 2.13.1 Eli Lilly Details
    • 2.13.2 Eli Lilly Major Business
    • 2.13.3 Eli Lilly Orphan Drugs Product and Solutions
    • 2.13.4 Eli Lilly Orphan Drugs Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Eli Lilly Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Orphan Drugs Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Orphan Drugs by Company Revenue
    • 3.2.2 Top 3 Orphan Drugs Players Market Share in 2023
    • 3.2.3 Top 6 Orphan Drugs Players Market Share in 2023
  • 3.3 Orphan Drugs Market: Overall Company Footprint Analysis
    • 3.3.1 Orphan Drugs Market: Region Footprint
    • 3.3.2 Orphan Drugs Market: Company Product Type Footprint
    • 3.3.3 Orphan Drugs Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Orphan Drugs Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Orphan Drugs Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Orphan Drugs Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Orphan Drugs Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Orphan Drugs Consumption Value by Type (2019-2030)
  • 6.2 North America Orphan Drugs Market Size by Application (2019-2030)
  • 6.3 North America Orphan Drugs Market Size by Country
    • 6.3.1 North America Orphan Drugs Consumption Value by Country (2019-2030)
    • 6.3.2 United States Orphan Drugs Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Orphan Drugs Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Orphan Drugs Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Orphan Drugs Consumption Value by Type (2019-2030)
  • 7.2 Europe Orphan Drugs Consumption Value by Application (2019-2030)
  • 7.3 Europe Orphan Drugs Market Size by Country
    • 7.3.1 Europe Orphan Drugs Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Orphan Drugs Market Size and Forecast (2019-2030)
    • 7.3.3 France Orphan Drugs Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Orphan Drugs Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Orphan Drugs Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Orphan Drugs Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Orphan Drugs Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Orphan Drugs Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Orphan Drugs Market Size by Region
    • 8.3.1 Asia-Pacific Orphan Drugs Consumption Value by Region (2019-2030)
    • 8.3.2 China Orphan Drugs Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Orphan Drugs Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Orphan Drugs Market Size and Forecast (2019-2030)
    • 8.3.5 India Orphan Drugs Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Orphan Drugs Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Orphan Drugs Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Orphan Drugs Consumption Value by Type (2019-2030)
  • 9.2 South America Orphan Drugs Consumption Value by Application (2019-2030)
  • 9.3 South America Orphan Drugs Market Size by Country
    • 9.3.1 South America Orphan Drugs Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Orphan Drugs Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Orphan Drugs Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Orphan Drugs Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Orphan Drugs Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Orphan Drugs Market Size by Country
    • 10.3.1 Middle East & Africa Orphan Drugs Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Orphan Drugs Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Orphan Drugs Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Orphan Drugs Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Orphan Drugs Market Drivers
  • 11.2 Orphan Drugs Market Restraints
  • 11.3 Orphan Drugs Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Orphan Drugs Industry Chain
  • 12.2 Orphan Drugs Upstream Analysis
  • 12.3 Orphan Drugs Midstream Analysis
  • 12.4 Orphan Drugs Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because they are so rare, would not be profitable to produce without government assistance. The conditions are referred to as orphan diseases.
    According to our (Global Info Research) latest study, the global Orphan Drugs market size was valued at US$ 157560 million in 2023 and is forecast to a readjusted size of USD 297800 million by 2030 with a CAGR of 9.6% during review period.
    Bristol-Myers Squibb is one of the most important global key players of orphan drugs, holds a share of about 10%, other key players include Roche and Novartis, etc. North America is the largest market, occupied for about 40 percent, followed by Asia-Pacific. In terms of type, oncology is the largest segment, with a share of over 60%, and in terms of application, the adult segment holds a share of about 40 percent.
    This report is a detailed and comprehensive analysis for global Orphan Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Orphan Drugs market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Orphan Drugs market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Orphan Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Orphan Drugs market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Orphan Drugs
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Orphan Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bristol-Myers Squibb, Roche, Novartis, Johnson & Johnson, Pfizer, Amgen, Sanofi, AstraZeneca, Takeda, Vertex Pharmaceuticals, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Orphan Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Orphan Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oncology
    Pulmonary
    Neurology
    Hematology
    Endocrinology
    Cardio-vascular
    Metabolic Disorders
    Others
    Market segment by Application
    Baby and Child
    Teenager
    Adult
    Other
    Market segment by players, this report covers
    Bristol-Myers Squibb
    Roche
    Novartis
    Johnson & Johnson
    Pfizer
    Amgen
    Sanofi
    AstraZeneca
    Takeda
    Vertex Pharmaceuticals
    AbbVie
    Biogen
    Eli Lilly
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Orphan Drugs product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Orphan Drugs, with revenue, gross margin, and global market share of Orphan Drugs from 2019 to 2024.
    Chapter 3, the Orphan Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Orphan Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Orphan Drugs.
    Chapter 13, to describe Orphan Drugs research findings and conclusion.

    Buy now